Active Funding Opportunity Announcements (FOAs) for All NICHD

NICHD issues and participates in various FOAs to support research activities and training.

Investigator-Initiated (Unsolicited) Projects

To submit unsolicited or investigator-initiated applications, use the appropriate NIH Parent Announcement.

Active FOAs for NICHD

Announcement Number Submissions Date(s) Expiration Date Activity Code(s) Title Sort descending
PA-18-504 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

The first standard due date for this FOA is February 25, 2018.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
January 8, 2021 R15 Academic Research Enhancement Award (Parent R15 Clinical Trial Not Allowed)
PA-16-200 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. May 8, 2019 R15 Academic Research Enhancement Award (Parent R15)
PA-18-343 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
The first standard due date for this FOA is February 25, 2018
January 8, 2021 R15 Academic Research Enhancement Award (R15 Clinical Trial Required)
PAR-18-714 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. May 8, 2021 R15 Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)
PAR-18-747 June 14, 2018, November 14, 2018, June 14, 2019, November 14, 2019, June 15, 2020, November 13, 2020 by 5:00 PM local time of applicant organization. November 14, 2020 R01 Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R01 Clinical Trial Optional)
PAR-18-745 June 14, 2018, November 14, 2018, June 14, 2019, November 14, 2019, June 15, 2020 and November 13, 2020 by 5:00 PM local time of applicant organization. November 14, 2020 R21 Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R21 Clinical Trial Optional)
PA-18-658 March 26, 2018, by 5:00 PM local time of applicant organization. March 27, 2018 333 Administrative Supplement for Research on Sex/Gender Influences (Admin Supp - Clinical Trial Optional)
PA-18-702 June 1, 2018, and August 1, 2018, by 5:00 PM local time of applicant organization. August 2, 2018 333 Administrative Supplements for Participation in the Concept to Clinic: Commercializing Innovation (C3i) Program (Admin Supp - Clinical Trial Not Allowed)
PA-17-307 October 15, 2017; January 15, 2018; or April 15, 2018, by 5:00 local time of applicant organization.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
April 16, 2018 333 Administrative Supplements for Research on Dietary Supplements (Admin Supp)
PA-18-817 October 15, 2018; January 15, 2019; April 15, 2019; October 15, 2019; January 15, 2020; or April 15, 2020, by 5:00 PM local time of applicant organization.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
April 16, 2020 333 Administrative Supplements for Research on Dietary Supplements (Admin. Supp.- Clinical Trial Not Allowed)
PA-16-287 May 26, 2019 333 Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Admin Supp)
PA-18-591 Due dates may vary by awarding IC. See the awarding IC web site for any applicable Application Due Dates. January 26, 2021 333 Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional)
PA-15-135 Multiple dates, see announcement. May 8, 2018 R01 Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01)
RFA-HD-18-101 January 22, 2018, by 5:00 PM local time of applicant organization.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
January 23, 2018 R41/R42 Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R41/R42)
RFA-HD-18-034 January 10, 2018 , by 5:00 PM local time of applicant organization.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
January 11, 2018 R41/R42 Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R41/R42)
RFA-HD-18-102 January 22, 2018, by 5:00 PM local time of applicant organization.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
January 23, 2018 R43/R44 Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R43/R44)
RFA-HD-18-033 January 10, 2018, by 5:00 PM local time of applicant organization.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
January 11, 2018 R43/R44 Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R43/R44)
PA-18-001 Multiple dates, see announcement. May 8, 2018 R01 Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional)
PA-15-127 Multiple dates, see announcement. May 8, 2018 R01 Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01)
PA-18-092 Multiple dates, see announcement. September 8, 2019 R21 Advancing Understanding, Prevention and Management of Infections Transmitted from Women to their Infants (R21 Clinical Trial Optional)
top of pageBACK TO TOP